#United States #Sanofi #Morristown, NJ #Keke Palmer #BEYFORTUS

Keke Palmer and Sanofi Join Forces to Combat RSV

In a groundbreaking campaign launched by Sanofi, Emmy Award-winning actress and entrepreneur Keke Palmer is rallying parents to take actionable steps in safeguarding their infants against Respiratory Syncytial Virus (RSV), a leading cause of hospitalization in babies under one year old. This partnership aims to educate families on the significance of preventive measures against this serious lung infection, particularly through the use of BEYFORTUS® (nirsevimab-alip).

With her personal experience as a mother, Palmer emphasizes the urgency of discussions surrounding RSV and its associated risks. “As moms, we spend so much time preparing for our baby's arrival and thinking about how to help keep them healthy,” Palmer remarked. “That includes being aware of RSV and the risk it poses during a baby's first year of life.” Through her involvement with Sanofi, she encourages other parents to engage in conversations with healthcare professionals regarding the best protection plans for their little ones.

BEYFORTUS has gained significant traction, having been chosen by over 11 million parents in the United States for its effectiveness in preventing serious RSV lung infections. The product is a monoclonal antibody treatment that has shown to be effective in protecting newborns and infants entering their first RSV season, as well as children up to 24 months who remain susceptible to severe RSV.

The messaging comes at a crucial time as families prepare for the upcoming RSV season, which spans from fall to spring in many regions. Parents are advised to consult their child’s pediatrician right away to avoid missing out on this vital immunization opportunity before the onset of the season. Palmer's own son received BEYFORTUS following a discussion with his doctor about RSV prevention, reinforcing the notion that proactive health strategies are necessary during this vulnerable phase.

RSV is widely known to be a highly contagious virus. Though many infants will exhibit mild, cold-like symptoms, it can escalate to serious respiratory issues, making it imperative for parents to be vigilant. Statistics indicate that over half of all babies will contract RSV before their first birthday, underscoring the threat this virus poses.

“Our ambition is all infant protection, all season,” stated Ayman Chit, Head of North America Medical for Vaccines at Sanofi. He reiterated that discussing RSV with healthcare providers is crucial for early intervention, allowing parents to secure their babies’ health effectively. BEYFORTUS is designed to provide ready-made antibodies, imparting rapid protection against RSV for up to five months—the typical length of an RSV season.

By joining forces with Keke Palmer, Sanofi aims to further amplify the message of RSV awareness. The shared goal is not only to inform but to actively inspire parents to prioritize vaccinations and preventive measures. Keke Palmer's role in this campaign reflects a commitment to community health and a heartfelt call to action for all parents.

For more details about BEYFORTUS and serious RSV lung infection prevention, families are encouraged to visit BEYFORTUS.com and consult with their healthcare providers. Palmer’s involvement is a clear reminder that awareness can lead to proactive healthcare choices, ultimately saving lives in the most vulnerable population.